Navigation Links
Governor Corbett: Lancaster County Commercial Lab to Expand, Create 200 New Jobs

HARRISBURG, Pa., July 25, 2012 /PRNewswire-USNewswire/ -- Governor Tom Corbett announced today that Eurofins Lancaster Laboratories will expand its operations in Pennsylvania by constructing a new laboratory facility in Lancaster County and creating 200 new jobs. 

"Eurofins Lancaster Laboratories is a true Pennsylvania success that continues to grow and create jobs in the region," said Corbett. "Today's announcement means that the company will grow from 844 employees to more than 1,000 employees. The impact on the community is significant and one the commonwealth is proud to support."

Eurofins Lancaster Laboratories will construct a four-story, 78,000-square-foot laboratory building on its existing campus which will be used for biopharmaceutical, pharmaceutical and food testing. The company will invest more than $17 million to build the new facility and purchase new lab equipment. Eurofins Lancaster Laboratories will retain its existing 844 Pennsylvania employees and create at least 200 new jobs within four years.      

The company received a $700,000 funding offer from the Department of Community and Economic Development, including a $300,000 Pennsylvania First grant and $400,000 in Job Creation Tax Credits.    

"We are pleased to announce this significant expansion of our operations in Lancaster County and are very appreciative of the support from the Commonwealth of Pennsylvania. This project is another example of the commitment of Eurofins Scientific to continued growth and investment in its laboratory operations in North America," said Dr. Timothy S. Oostdyk, president, Eurofins Lancaster Laboratories.

The project was coordinated by the Governor's Action Team, or GAT, a group of economic development professionals who work directly with businesses that are considering locating or expanding in Pennsylvania. GAT provides site selection assistance, coordinates the involvement of other state agencies as needed, and packages the appropriate economic development funding for the project.

Founded in 1961, Eurofins Lancaster Laboratories is one of the largest commercial contract laboratories in the world providing comprehensive laboratory services in the pharmaceutical, biopharmaceutical and environmental sciences. The laboratory serves clients from a diverse range of businesses and industries and also serves local and national governments. For more information about Eurofins Lancaster Laboratories, visit

For more information on the Governor's Action Team and other economic development initiatives in Pennsylvania, visit or call 1-866-466-3972.

Media contacts:

Kelli Roberts, Governor's Office; 717-783-1116
Steven Kratz, DCED; 717-783-1132

SOURCE Pennsylvania Office of the Governor
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
2. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
3. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
4. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
5. Healthscope to commercially launch Circadians Cancers of Unknown Primary Diagnostic Test
6. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
7. Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions
8. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
9. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
10. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
11. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... of Toronto and the University of British Columbia suggested that laws requiring bicyclists to ... article explains that part of the reason for the controversial conclusion is that, while ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... Lizzie’s ... , The company is offering customers 10% off of their purchase of lice treatment ... treatment at full price. According to a company spokesperson. “Finding lice is a sure ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in ... (see Table 1-1 ). More than 3.7 billion people under the age of ... 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , "The ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
Breaking Medicine News(10 mins):